GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » Beneish M-Score

Rua Bioscience (NZSE:RUA) Beneish M-Score : -4.89 (As of Sep. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Rua Bioscience Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.89 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Rua Bioscience's Beneish M-Score or its related term are showing as below:

NZSE:RUA' s Beneish M-Score Range Over the Past 10 Years
Min: -38.08   Med: -21.49   Max: -4.89
Current: -4.89

During the past 4 years, the highest Beneish M-Score of Rua Bioscience was -4.89. The lowest was -38.08. And the median was -21.49.


Rua Bioscience Beneish M-Score Historical Data

The historical data trend for Rua Bioscience's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rua Bioscience Beneish M-Score Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Beneish M-Score
- - -38.08 -4.89

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beneish M-Score Get a 7-Day Free Trial - - -38.08 - -4.89

Competitive Comparison of Rua Bioscience's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Rua Bioscience's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rua Bioscience's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rua Bioscience's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Rua Bioscience's Beneish M-Score falls into.



Rua Bioscience Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Rua Bioscience for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3361+0.528 * -0.0366+0.404 * 0.5684+0.892 * 0.2402+0.115 * 1.0008
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.129845-0.327 * 3.1732
=-4.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun24) TTM:Last Year (Jun23) TTM:
Total Receivables was NZ$0.28 Mil.
Revenue was NZ$0.09 Mil.
Gross Profit was NZ$-0.12 Mil.
Total Current Assets was NZ$2.82 Mil.
Total Assets was NZ$7.74 Mil.
Property, Plant and Equipment(Net PPE) was NZ$2.65 Mil.
Depreciation, Depletion and Amortization(DDA) was NZ$0.40 Mil.
Selling, General, & Admin. Expense(SGA) was NZ$0.00 Mil.
Total Current Liabilities was NZ$0.87 Mil.
Long-Term Debt & Capital Lease Obligation was NZ$0.10 Mil.
Net Income was NZ$-13.72 Mil.
Gross Profit was NZ$-8.98 Mil.
Cash Flow from Operations was NZ$-3.74 Mil.
Total Receivables was NZ$0.86 Mil.
Revenue was NZ$0.36 Mil.
Gross Profit was NZ$0.02 Mil.
Total Current Assets was NZ$5.60 Mil.
Total Assets was NZ$20.95 Mil.
Property, Plant and Equipment(Net PPE) was NZ$4.54 Mil.
Depreciation, Depletion and Amortization(DDA) was NZ$0.69 Mil.
Selling, General, & Admin. Expense(SGA) was NZ$0.00 Mil.
Total Current Liabilities was NZ$0.76 Mil.
Long-Term Debt & Capital Lease Obligation was NZ$0.07 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.277 / 0.086) / (0.863 / 0.358)
=3.22093 / 2.410615
=1.3361

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.018 / 0.358) / (-0.118 / 0.086)
=0.050279 / -1.372093
=-0.0366

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2.817 + 2.653) / 7.74) / (1 - (5.602 + 4.539) / 20.951)
=0.293282 / 0.515966
=0.5684

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.086 / 0.358
=0.2402

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.685 / (0.685 + 4.539)) / (0.4 / (0.4 + 2.653))
=0.131126 / 0.131019
=1.0008

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 0.086) / (0 / 0.358)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.099 + 0.874) / 7.74) / ((0.068 + 0.762) / 20.951)
=0.125711 / 0.039616
=3.1732

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-13.719 - -8.978 - -3.736) / 7.74
=-0.129845

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Rua Bioscience has a M-score of -4.89 suggests that the company is unlikely to be a manipulator.


Rua Bioscience Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Rua Bioscience's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Rua Bioscience Business Description

Traded in Other Exchanges
N/A
Address
1 Commerce Place, Awapuni, Gisborne, NZL, 4071
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Germany and New Zealand.

Rua Bioscience Headlines

No Headlines